financetom
Business
financetom
/
Business
/
iA Financial Q2 profit rises, dividend rises 10%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
iA Financial Q2 profit rises, dividend rises 10%
Aug 5, 2025 2:45 PM

Overview

* IA Financial ( IAFNF ) Q2 core EPS rises 27% YoY, beating analyst expectations, per LSEG data

* EPS for Q2 increases 62% YoY, reflecting strong profitability

* Company announces 10% dividend increase

Outlook

* IA Financial ( IAFNF ) expects RF Capital acquisition to be neutral to core earnings in first year

* Upon deal completion, company projects RF Capital deal to add over C$40 bln in assets under administration

* Company anticipates core EPS accretion of C$0.15 from RF Capital deal in second year

Result Drivers

* EXPERIENCE GAINS - Significant experience gains across business units drove strong profitability, per CFO Éric Jobin

* SALES MOMENTUM - Strong sales in Canada and U.S. contributed to 16% growth in assets under management and administration

* CAPITAL GENERATION - Record quarterly organic capital generation of C$200 mln strengthened capital position

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat C$3.49 C$3.06

Adjusted (6

EPS Analysts

)

Q2 EPS C$3.43

Q2 Net C$321

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the life & health insurance peer group is "buy"

* Wall Street's median 12-month price target for iA Financial Corporation Inc ( IAFNF ) is C$144.50, about 6.3% above its August 1 closing price of C$135.34

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
O Reilly Automotive Insider Sold Shares Worth $2,022,017, According to a Recent SEC Filing
O Reilly Automotive Insider Sold Shares Worth $2,022,017, According to a Recent SEC Filing
Feb 28, 2025
04:30 PM EST, 02/28/2025 (MT Newswires) -- Tamara F. Conn, Senior Vice President, Legal and General Counsel, on February 26, 2025, sold 1,524 shares in O Reilly Automotive (ORLY) for $2,022,017. Following the Form 4 filing with the SEC, Conn has control over a total of 296 common shares of the company, with 281 shares held directly and 15 controlled...
Sps Commerce Insider Sold Shares Worth $754,654, According to a Recent SEC Filing
Sps Commerce Insider Sold Shares Worth $754,654, According to a Recent SEC Filing
Feb 28, 2025
04:32 PM EST, 02/28/2025 (MT Newswires) -- Kimberly K. Nelson, Executive Vice President & CFO, on February 26, 2025, sold 5,490 shares in Sps Commerce ( SPSC ) for $754,654. Following the Form 4 filing with the SEC, Nelson has control over a total of 152,220 common shares of the company, with 151,752 shares held directly and 468 controlled indirectly....
Olin Prices $600 Million Senior Notes Offering
Olin Prices $600 Million Senior Notes Offering
Feb 28, 2025
04:30 PM EST, 02/28/2025 (MT Newswires) -- Olin (OLN) said Friday it priced a private offering of $600 million aggregate principal amount of 6.625% senior notes due 2033. The offering is expected to close on March 14, pending customary closing conditions. The company said it intends to use the proceeds, along with borrowings from new credit facilities, to redeem all...
Vertex Pharmaceuticals Insider Sold Shares Worth $610,560, According to a Recent SEC Filing
Vertex Pharmaceuticals Insider Sold Shares Worth $610,560, According to a Recent SEC Filing
Feb 28, 2025
04:31 PM EST, 02/28/2025 (MT Newswires) -- David Altshuler, Executive Vice President, Chief Scientific Officer, on February 26, 2025, sold 1,272 shares in Vertex Pharmaceuticals ( VRTX ) for $610,560. Following the Form 4 filing with the SEC, Altshuler has control over a total of 32,974 common shares of the company, with 32,974 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/875320/000087532025000120/xslF345X05/wk-form4_1740777806.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved